Cannabis Law Report

JULY 25, 2022

Psychedelics, medicine and ethics has always been a tricky thing and we’re suprised (or maybe not) that those who have held themselves up to be the paragons of perfection in the field over the past few years, have in fact been either arrogant, dumb or lazy when it comes to managing ethics at their organisations.

Medicine 52

Medicine Therapy Research and Development Business 52

MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. As more physicians and healthcare professionals advocate for the integration of medical marijuana into treatment plans, public trust in its medicinal value has grown.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JANUARY 12, 2022

The National Psychedelics Association is a non-profit advancing equitable access to safe psychedelic-assisted therapies through awareness, advocacy, and education. Maya envisions a future where everyone has the opportunity to benefit from safe and accessible psychedelic medicine. ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. Now, psychedelic research is booming. Ayahuasca .

History 119

History Microdosing Research and Development Clinical Trials 119

Veriheal

AUGUST 31, 2020

These students showed knowledge and passion for the future of cannabis and posed revolutionary ideas rooted in their training across business, agriculture, biochemistry, public health, pharmacology, medicine, and liberal arts. . Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”.

Research and Development 117

Research and Development Education Agriculture Patients 117

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Legislation to legalize the medicinal use of marijuana for dogs, cats and other pets in New York State is pending in the Assembly (A. Additionally, a bipartisan coalition of U.S.

Legislation 160

Legislation Decriminalization Access Therapy 160

Cannabis Law Report

AUGUST 25, 2022

The MAPS Policy and Advocacy team coordinated a bipartisan coalition that met with U.S. Policy and Advocacy Director, MAPS. In addition to the clinical research program to make MDMA into an FDA-approved medicine, MAPS was founded to create sensible and compassionate alternatives to the War on Drugs. Ismail L Ali, J.D.,

Research and Development 52

Research and Development Advocacy Clinical Trials Policy 52

Cannabis Law Report

JUNE 10, 2021

9-tetrahydrocannabinol on driving performance: a randomized clinical trial. Department of Pediatrics, College of Medicine, The Ohio State University, 370 W. Article Google Scholar. Arkell TR, Vinckenbosch F, Kevin RC, Theunissen EL, McGregor IS, Ramaekers JG. Effect of cannabidiol and ?9-tetrahydrocannabinol Contributions.

Policy 59

Policy Safety Marijuana Data 59

Cannabis Law Report

SEPTEMBER 21, 2021

He also is a member of the Board of Directors at the Bend Chamber of Commerce and the Chamber’s Advocacy Committee. If we are going to provide medicinal cannabis opportunities covered by insurance, we need the ability to go through clinical trials and testing. Hunter Talks To Trichomes February 2021.

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.

Research and Development 52

Research and Development Medicine Access Media 52

SMPL

MAY 26, 2020

That’s because the federal government’s insistence that cannabis has no legitimate use as a medicine created two enormous problems: the proliferation of fake CBD products and the nonsensical separation of CBD from THC. Mr. Gardner, the writer whose CBD advocacy eventually inspired the 2011 summit at Ms. Miller told me.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

DECEMBER 22, 2021

We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. They have what they call a herbal medicine. It’s difficult to argue, because they look at it like they look at other herbal medicine.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

The Cannigma

MAY 7, 2021

This is where the crux of the issue is, if you are a patient then you have epilepsy or your child has epilepsy, you want a qualified product that you can rely on that has the same level of provision in relation to the manufacturing process as any other medicine that you would take.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

OCTOBER 20, 2021

s NORML Coordinator Dale Gieringer, Delta-8 has undergone minimal testing in humans, “therefore, little is known about its long-term safety, its consumption at high dosages, or its medicinal effects.” Additionally, the advocacy group views Delta-8 THC as a Schedule I substance under federal law. According to Calif.’s

Hemp 52

Hemp Clinical Trials CBD Legalization 52

Cannabis Law Report

JUNE 4, 2021

Although psychedelics have been used by humans for over 7,000 years across multiple different cultures, only in the past century have these medicines been outlawed by governments around the world. Fortunately, the past several years have seen a resurgence in awareness and interest in psychedelic medicine. in/timferriss/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

NORML

JANUARY 28, 2019

National Library of Medicine has more than 26,000 published studies/reviews across 24 databases regarding cannabis available to read online. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine.

Data 187

Data Clinical Trials Chronic Pain Medicine 187